What is Molecular Testing Labs?
Molecular Testing Labs is dedicated to enhancing access to diagnostic testing, particularly in areas where geographic, financial, or social barriers impede healthcare delivery. By leveraging custom technology systems, advanced logistics, and robust research and development, MTL is transforming the accessibility of diagnostics. The company collaborates with a diverse network of partners, including retailers, pharmacies, digital health providers, research institutions, public health departments, community-based organizations, 340B and Federally Qualified Health Centers, clinics, long-term care facilities, and payer networks, to deliver its laboratory solutions.
How much funding has Molecular Testing Labs raised?
Molecular Testing Labs has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Molecular Testing Labs
PPP
Public-Private Partnership
What's next for Molecular Testing Labs?
The substantial enterprise-level funding indicates Molecular Testing Labs is poised for significant scaling and further innovation. This capital infusion is expected to fuel the expansion of its diagnostic reach, enhance its technological infrastructure, and deepen its research into novel testing methodologies. The strategic nature of the recent investment suggests a focus on strengthening market position and forging key alliances to further its mission of improving health equity and outcomes across underserved populations.
See full Molecular Testing Labs company page
